CardioAI:一种基于多模态人工智能的系统,用于支持癌症治疗引起的心脏毒性的症状监测和风险检测
CardioAI: A Multimodal AI-based System to Support Symptom Monitoring and Risk Detection of Cancer Treatment-Induced Cardiotoxicity
AI总结:
针对癌症治疗引发的心脏毒性监测难题,CardioAI系统结合可穿戴设备与大语言模型语音助手,提供可解释的风险预测,经专家评估能有效融入临床工作流程并辅助决策。
摘要:
尽管近期癌症治疗的进展延长了患者的生命,但治疗引起的心脏毒性仍然是一种严重的副作用。心脏毒性的临床决策具有挑战性,因为非临床症状可能在后期发生危及生命的事件之前被忽略,而临床医生的工作量已经高度集中于治疗本身,而非副作用。我们的项目首先与11名临床医生进行了一项参与式设计研究,以了解他们的实践和需求;随后我们构建了一个多模态人工智能系统CardioAI,该系统整合了可穿戴设备和基于大语言模型的语音助手,以监测多模态非临床症状。此外,该系统还包含一个可解释的风险预测模块,能够生成心脏毒性风险评分和作为解释的摘要,以支持临床医生的决策。我们与四位临床专家进行了启发式评估,发现他们都认为CardioAI能够很好地融入他们的工作流程,减少信息过载,并使他们能够做出更明智的决策。
英文摘要:
Despite recent advances in cancer treatments that prolong patients' lives, treatment-induced cardiotoxicity remains one severe side effect. The clinical decision-making of cardiotoxicity is challenging, as non-clinical symptoms can be missed until life-threatening events occur at a later stage, and clinicians already have a high workload centered on the treatment, not the side effects. Our project starts with a participatory design study with 11 clinicians to understand their practices and needs; then we build a multimodal AI system, CardioAI, that integrates wearables and LLM-powered voice assistants to monitor multimodal non-clinical symptoms. Also, the system includes an explainable risk prediction module that can generate cardiotoxicity risk scores and summaries as explanations to support clinicians' decision-making. We conducted a heuristic evaluation with four clinical experts and found that they all believe CardioAI integrates well into their workflow, reduces their information overload, and enables them to make more informed decisions.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。